Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy

Clinical Nuclear Medicine

Volumn 39, Issue 1, 2014, Pages

  Cortés Romera, Montserrat ^a   Sabaté Llobera, Aida ^a   Mercadal Vilchez, Santiago ^b   Climent Esteller, Fina ^a   Serrano Maestro, Alfons ^b   Gámez Cenzano, Cristina ^a   González Barca, Eva ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Bone marrow biopsy; Bone marrow involvement; Concordance; Lymphoma; PET CT

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; BONE MARROW INFILTRATION; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OSTEOLYSIS; PET-CT SCANNER; PREDICTIVE VALUE; SCLEROSIS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BONE MARROW; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84891558608     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31828e9504     Document Type: Article

References (24)

1. Pelosi E, Penna D, Deandreis D, et al. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Q J Nucl Med Mol Imaging. 2008; 52:9-16
2. Moulin-Romsee G, Hindié E, Cuenca X, et al. 18F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl MedMol Imaging. 2010; 37:1095-1105
3. Levis A, Pietrasanta D, Godio L, et al. A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma. Clin Lymphoma. 2004;5: 50-55
4. Ponzoni M, Ciceri F, Crocchiolo R, et al. Isolated bone marrow occurrence of classic Hodgkin's lymphoma in an HIV-negative patient. Haematologica. 2006; 91:ECR04
5. Bremnes RM, Bremnes Y, Dønnem T. High-grade non-Hodgkin's lymphoma treated in northern NorwayVtreatment, outcome, and prognostic factors. Acta Oncol. 1999;38:117-124
6. Brusamolino E, Bacigalupo A, Barosi G, et al. Classical Hodgkin's lymphoma in adults: Guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up. Haematologica. 2009; 94:550-565
7. Howell SJ, Grey M, Chang J, et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: A review of 955 cases seen in a regional cancer centre. Br J Haematol. 2002;119:408-411
8. Moog F, Bangerter M, Kotzerke J, et al. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol. 1998;16:603-609
9. Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood. 1998;91:3340-3346
10. Hong J, Lee Y, Park Y, et al. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Ann Hematol. 2012;91:687-695
11. Fuster D, Chiang S, Andreadis C, et al. Can [18F]Fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma? Nucl Med Commun. 2006;27:11-15
12. Schaefer NG, Hany TF, Taverna C, et al. Non Hodgkin Lymphoma and Hodgkin disease: Coregistered FDG PET and CT at staging and restaging: Do we need contrast-enhanced CT? Radiology. 2004;232:823-829
13. Jerusalem G, Beguin Y, Najjar F, et al. Positron emission tomography (PET) with 18F-FDG for the staging of low grade non-Hodgkin's Lymphoma. Ann Oncol. 2001;12:825-830
14. Hutchings M, Loft A, Hansen M, et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica. 2006;91:482-489
15. Seam P, JuweidME, Cheson B. The role of FDG-PET in patientswith lymphoma. Blood. 2007;110:3507-3516
16. Pakos E, Fotopoulos A, Ioannnidis J. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: A meta-Analysis. J Nucl Med. 2005; 46:958-963
17. Pelosi E, Penna D, Douroukas A, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: Results from a large multicentre study. Q J Nucl Med Mol Imaging. 2011;55:469-475
18. Kand PG, Tiwari BP, Basu S, et al. Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter. Indian J Cancer. 2010;47:380-384
19. Ribrag V, Vanel D, Leboulleux S, et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: Wholebody MRI, PET/CT and bone marrow biopsy. Eur J Radiol. 2008;66:325-331
20. Inoue K, Goto R, Okada K, et al. A bone marrow 18F-FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Ann Nucl Med. 2009; 23:643-649
21. Agool A, Glaudemans AW, Boersma HH, et al. Radionuclide imaging of bone marrow disorders. Eur J Nucl Med Mol Imaging. 2011;38:166-178
22. Salaun P, Gastinne T, Bodet-Milin C, et al. Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: A reflection of disease infiltration or just inflammatioñ. Eur J Nucl Med Mol Imaging. 2009;36:1813-1821
23. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J NuclMed. 2005;46:1356-1367
24. Jacene H. FDG-PET and PET/CT in lymphoma. In: Wahl R, ed. Clinical PET and PET/CT Imaging. RSNA Categorical Course in Diagnostic Radiology. Chicago, IL: RSNA; 2007:123-131